SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2oap'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BDW_B_DVAB8_0
(GRAMICIDIN A)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 291
VAL 1 339
TRP 1 306
 None
 0.89A 1bdwA-2oap1:
undetectable
1bdwB-2oap1:
undetectable		 1bdwA-2oap1:
3.58
1bdwB-2oap1:
3.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1DTL_A_BEPA206_1
(CARDIAC TROPONIN C)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		4 / 8 PRO 1 500
GLU 1 501
GLU 1 463
ASP 1 466
 None
 1.14A 1dtlA-2oap1:
undetectable		 1dtlA-2oap1:
17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 12 ALA 1  58
ILE 1 158
PRO 1 155
VAL 1 171
ILE 1 170
 None
 1.08A 1hsgB-2oap1:
undetectable		 1hsgB-2oap1:
13.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RI4_A_SAMA299_0
(MRNA CAPPING ENZYME)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 12 GLY 1 357
ILE 1 337
PHE 1 261
SER 1 262
TYR 1 361
 None
 1.05A 1ri4A-2oap1:
undetectable		 1ri4A-2oap1:
20.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1S9Q_A_CHDA459_0
(ESTROGEN-RELATED
RECEPTOR GAMMA)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		4 / 6 ASP 1 173
LEU 1 172
VAL 1 171
ILE 1 170
 None
 0.96A 1s9qA-2oap1:
undetectable		 1s9qA-2oap1:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 12 ALA 1  58
ILE 1 158
PRO 1 155
VAL 1 171
ILE 1 170
 None
 1.04A 1sduB-2oap1:
undetectable		 1sduB-2oap1:
11.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BM9_C_SAMC301_0
(CEPHALOSPORIN
HYDROXYLASE CMCI)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		6 / 12 LEU 1 426
GLU 1 412
ASN 1 370
ASN 1 414
ALA 1 394
ALA 1 263
 None
 1.38A 2bm9C-2oap1:
undetectable		 2bm9C-2oap1:
19.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HYY_C_STIC600_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		4 / 6 LEU 1 253
VAL 1 373
MET 1 372
ILE 1 264
 None
 0.90A 2hyyC-2oap1:
undetectable		 2hyyC-2oap1:
19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NNK_A_ROCA401_2
(PROTEASE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 ARG 1 409
VAL 1 265
THR 1 276
 None
 0.83A 2nnkA-2oap1:
undetectable		 2nnkA-2oap1:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W9G_A_TOPA1159_1
(DIHYDROFOLATE
REDUCTASE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 10 LEU 1 381
VAL 1 383
SER 1 362
ILE 1 264
PHE 1 351
 None
 1.14A 2w9gA-2oap1:
undetectable		 2w9gA-2oap1:
16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WA2_B_SAMB1267_1
(NON-STRUCTURAL
PROTEIN 5)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 SER 1 207
HIS 1   5
ASP 1 128
 None
 0.77A 2wa2B-2oap1:
2.9		 2wa2B-2oap1:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YFX_A_VGHA9000_1
(TYROSINE-PROTEIN
KINASE RECEPTOR)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 8 LEU 1 184
ALA 1 211
LEU 1 177
GLY 1 151
ASP 1 150
 None
 1.47A 2yfxA-2oap1:
undetectable		 2yfxA-2oap1:
19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FRE_X_TOPX300_1
(DIHYDROFOLATE
REDUCTASE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 9 LEU 1 381
VAL 1 383
SER 1 362
ILE 1 264
PHE 1 351
 None
 1.20A 3freX-2oap1:
undetectable		 3freX-2oap1:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K4V_B_ROCB201_2
(HIV-1 PROTEASE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 ARG 1 409
VAL 1 265
THR 1 276
 None
 0.80A 3k4vA-2oap1:
undetectable		 3k4vA-2oap1:
11.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3K4V_D_ROCD201_4
(HIV-1 PROTEASE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 ARG 1 409
VAL 1 265
THR 1 276
 None
 0.82A 3k4vD-2oap1:
undetectable		 3k4vD-2oap1:
11.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDT_A_ROCA101_2
(PROTEASE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 ARG 1 409
VAL 1 265
THR 1 276
 None
 0.61A 3ndtA-2oap1:
undetectable		 3ndtA-2oap1:
11.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NDU_D_ROCD100_3
(PROTEASE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 ARG 1 409
VAL 1 265
THR 1 276
 None
 0.83A 3nduD-2oap1:
undetectable		 3nduD-2oap1:
11.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PWR_A_ROCA401_2
(PROTEASE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 ARG 1 409
VAL 1 265
THR 1 276
 None
 0.85A 3pwrA-2oap1:
undetectable		 3pwrA-2oap1:
11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TL9_A_ROCA401_2
(PROTEASE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 ARG 1 409
VAL 1 265
THR 1 276
 None
 0.82A 3tl9A-2oap1:
undetectable		 3tl9A-2oap1:
14.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VRJ_A_1KXA301_1
(HLA CLASS I
HISTOCOMPATIBILITY
ANTIGEN, B-57 ALPHA
CHAIN
10-MER PEPTIDE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 12 TYR 1  56
ILE 1 158
VAL 1 144
THR 1  41
ILE 1 156
 None
 1.28A 3vrjA-2oap1:
undetectable
3vrjC-2oap1:
undetectable		 3vrjA-2oap1:
19.22
3vrjC-2oap1:
5.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A9K_A_TYLA2200_1
(CREB-BINDING PROTEIN)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		4 / 6 VAL 1 342
LEU 1 364
ILE 1 264
VAL 1 383
 None
 0.76A 4a9kA-2oap1:
undetectable		 4a9kA-2oap1:
14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A9K_B_TYLB2198_1
(CREB-BINDING PROTEIN)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		4 / 5 VAL 1 342
LEU 1 364
ILE 1 264
VAL 1 383
 None
 0.82A 4a9kB-2oap1:
undetectable		 4a9kB-2oap1:
14.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L3G_F_ACTF401_0
(METHYLAMINE
DEHYDROGENASE HEAVY
CHAIN)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 ARG 1 473
LEU 1 477
GLU 1 476
 None
 0.74A 4l3gF-2oap1:
undetectable		 4l3gF-2oap1:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PGF_A_ADNA502_2
(ADENOSYLHOMOCYSTEINA
SE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		4 / 6 GLU 1  60
THR 1  41
HIS 1 160
LEU 1 138
 None
 1.11A 4pgfA-2oap1:
undetectable		 4pgfA-2oap1:
26.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TWD_H_377H401_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		4 / 6 TYR 1 486
ASN 1 278
GLU 1 232
PHE 1 229
 None
 1.06A 4twdG-2oap1:
0.1
4twdH-2oap1:
undetectable		 4twdG-2oap1:
21.62
4twdH-2oap1:
21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZZC_B_ACTB401_0
(PROTON-GATED ION
CHANNEL)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		4 / 6 ILE 1 231
PHE 1 229
ILE 1 299
GLU 1 294
 None
 1.15A 4zzcB-2oap1:
undetectable
4zzcC-2oap1:
undetectable		 4zzcB-2oap1:
19.22
4zzcC-2oap1:
19.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KR0_A_478A101_1
(PROTEASE E35D-APV)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 9 ALA 1  58
ILE 1 158
PRO 1 155
VAL 1 171
ILE 1 170
 None
 1.10A 5kr0A-2oap1:
undetectable		 5kr0A-2oap1:
12.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGL_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.68A 5qglA-2oap1:
undetectable		 5qglA-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGU_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.66A 5qguA-2oap1:
undetectable		 5qguA-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGV_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.67A 5qgvA-2oap1:
undetectable		 5qgvA-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGW_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.65A 5qgwA-2oap1:
undetectable		 5qgwA-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGX_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.67A 5qgxA-2oap1:
undetectable		 5qgxA-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGY_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.67A 5qgyA-2oap1:
undetectable		 5qgyA-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QGZ_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.65A 5qgzA-2oap1:
undetectable		 5qgzA-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QH0_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.65A 5qh0A-2oap1:
undetectable		 5qh0A-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QH1_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.68A 5qh1A-2oap1:
undetectable		 5qh1A-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QH2_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.65A 5qh2A-2oap1:
undetectable		 5qh2A-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QH3_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.67A 5qh3A-2oap1:
undetectable		 5qh3A-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QH4_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.70A 5qh4A-2oap1:
undetectable		 5qh4A-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QH9_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.68A 5qh9A-2oap1:
undetectable		 5qh9A-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QHA_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.61A 5qhaA-2oap1:
undetectable		 5qhaA-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QHC_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.68A 5qhcA-2oap1:
undetectable		 5qhcA-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QHE_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.67A 5qheA-2oap1:
undetectable		 5qheA-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5QHF_A_ACTA301_0
(PEROXISOMAL COENZYME
A DIPHOSPHATASE
NUDT7)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 VAL 1 396
VAL 1 266
GLN 1 371
 None
 0.67A 5qhfA-2oap1:
undetectable		 5qhfA-2oap1:
16.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6CCV_C_RFPC1205_1
(-)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 12 ASP 1 141
SER 1 207
LEU 1 203
ARG 1 187
ILE 1 226
 None
 1.40A 6ccvC-2oap1:
undetectable		 6ccvC-2oap1:
18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DJ2_B_AB1B201_0
(HIV-1 PROTEASE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 10 ALA 1  58
ILE 1 158
PRO 1 155
VAL 1 171
ILE 1 170
 None
 1.00A 6dj2A-2oap1:
undetectable		 6dj2A-2oap1:
11.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_C_ADNC503_0
(ADENOSYLHOMOCYSTEINA
SE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 12 GLY 1 418
ASP 1 392
ASN 1 414
ILE 1 369
LYS 1 449
 None
 1.19A 6exiC-2oap1:
undetectable
6exiD-2oap1:
undetectable		 6exiC-2oap1:
10.92
6exiD-2oap1:
10.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_D_ADND503_0
(ADENOSYLHOMOCYSTEINA
SE)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		5 / 12 LYS 1 449
GLY 1 418
ASP 1 392
ASN 1 414
ILE 1 369
 None
 1.21A 6exiC-2oap1:
undetectable
6exiD-2oap1:
undetectable		 6exiC-2oap1:
10.92
6exiD-2oap1:
10.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 3
CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)		 2oap TYPE II SECRETION
SYSTEM PROTEIN
(Archaeoglobus
fulgidus) 		3 / 3 ARG 1 120
PHE 1 126
PHE 1 117
 None
 1.09A 6nknC-2oap1:
undetectable
6nknJ-2oap1:
undetectable		 6nknC-2oap1:
18.00
6nknJ-2oap1:
8.16